Review article: The modern diagnosis and therapy of cholangiocarcinoma

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Cholangiocarcinomas are epithelial neoplasms that originate from cholangiocytes and can occur at any level of the biliary tree. They are broadly classified into intrahepatic tumours, (extrahepatic) hilar tumours and (extrahepatic) distal bile duct tumours. In spite of well-understood predispositions, most cholangiocarcinomas arise in the absence of risk factors. In suspected cases, the diagnosis can be established with non-invasive imaging studies. Biliary invasion should be reserved for patients with obstruction. In high-risk patients, advanced cytological tests of aneuploidy (digital image analysis and fluorescent in situ hybridization) aid early diagnosis. In the absence of primary sclerosing cholangitis, curative surgical resection has 5-year survival rates of 2-43%, higher survival observed in patients with clear surgical margins and concomitant hepatic resection for hilar tumours. Patients with unresectable cholangiocarcinoma or pre-existing primary sclerosing cholangitis should be considered for liver transplantation with neoadjuvant chemoirradiation, in specialized centres.

Original languageEnglish (US)
Pages (from-to)1287-1296
Number of pages10
JournalAlimentary Pharmacology and Therapeutics
Volume23
Issue number9
DOIs
StatePublished - May 2006

Fingerprint

Cholangiocarcinoma
Sclerosing Cholangitis
Neoplasms
Extrahepatic Bile Ducts
Glandular and Epithelial Neoplasms
Biliary Tract
Aneuploidy
Therapeutics
Fluorescence In Situ Hybridization
Liver Transplantation
Early Diagnosis
Survival Rate
Survival
Liver

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Review article : The modern diagnosis and therapy of cholangiocarcinoma. / Malhi, Harmeet M; Gores, Gregory James.

In: Alimentary Pharmacology and Therapeutics, Vol. 23, No. 9, 05.2006, p. 1287-1296.

Research output: Contribution to journalArticle

@article{f673da2ac1f64351b3070ce4de4af785,
title = "Review article: The modern diagnosis and therapy of cholangiocarcinoma",
abstract = "Cholangiocarcinomas are epithelial neoplasms that originate from cholangiocytes and can occur at any level of the biliary tree. They are broadly classified into intrahepatic tumours, (extrahepatic) hilar tumours and (extrahepatic) distal bile duct tumours. In spite of well-understood predispositions, most cholangiocarcinomas arise in the absence of risk factors. In suspected cases, the diagnosis can be established with non-invasive imaging studies. Biliary invasion should be reserved for patients with obstruction. In high-risk patients, advanced cytological tests of aneuploidy (digital image analysis and fluorescent in situ hybridization) aid early diagnosis. In the absence of primary sclerosing cholangitis, curative surgical resection has 5-year survival rates of 2-43{\%}, higher survival observed in patients with clear surgical margins and concomitant hepatic resection for hilar tumours. Patients with unresectable cholangiocarcinoma or pre-existing primary sclerosing cholangitis should be considered for liver transplantation with neoadjuvant chemoirradiation, in specialized centres.",
author = "Malhi, {Harmeet M} and Gores, {Gregory James}",
year = "2006",
month = "5",
doi = "10.1111/j.1365-2036.2006.02900.x",
language = "English (US)",
volume = "23",
pages = "1287--1296",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Review article

T2 - The modern diagnosis and therapy of cholangiocarcinoma

AU - Malhi, Harmeet M

AU - Gores, Gregory James

PY - 2006/5

Y1 - 2006/5

N2 - Cholangiocarcinomas are epithelial neoplasms that originate from cholangiocytes and can occur at any level of the biliary tree. They are broadly classified into intrahepatic tumours, (extrahepatic) hilar tumours and (extrahepatic) distal bile duct tumours. In spite of well-understood predispositions, most cholangiocarcinomas arise in the absence of risk factors. In suspected cases, the diagnosis can be established with non-invasive imaging studies. Biliary invasion should be reserved for patients with obstruction. In high-risk patients, advanced cytological tests of aneuploidy (digital image analysis and fluorescent in situ hybridization) aid early diagnosis. In the absence of primary sclerosing cholangitis, curative surgical resection has 5-year survival rates of 2-43%, higher survival observed in patients with clear surgical margins and concomitant hepatic resection for hilar tumours. Patients with unresectable cholangiocarcinoma or pre-existing primary sclerosing cholangitis should be considered for liver transplantation with neoadjuvant chemoirradiation, in specialized centres.

AB - Cholangiocarcinomas are epithelial neoplasms that originate from cholangiocytes and can occur at any level of the biliary tree. They are broadly classified into intrahepatic tumours, (extrahepatic) hilar tumours and (extrahepatic) distal bile duct tumours. In spite of well-understood predispositions, most cholangiocarcinomas arise in the absence of risk factors. In suspected cases, the diagnosis can be established with non-invasive imaging studies. Biliary invasion should be reserved for patients with obstruction. In high-risk patients, advanced cytological tests of aneuploidy (digital image analysis and fluorescent in situ hybridization) aid early diagnosis. In the absence of primary sclerosing cholangitis, curative surgical resection has 5-year survival rates of 2-43%, higher survival observed in patients with clear surgical margins and concomitant hepatic resection for hilar tumours. Patients with unresectable cholangiocarcinoma or pre-existing primary sclerosing cholangitis should be considered for liver transplantation with neoadjuvant chemoirradiation, in specialized centres.

UR - http://www.scopus.com/inward/record.url?scp=33645718033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645718033&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2036.2006.02900.x

DO - 10.1111/j.1365-2036.2006.02900.x

M3 - Article

C2 - 16629933

AN - SCOPUS:33645718033

VL - 23

SP - 1287

EP - 1296

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 9

ER -